Investor Presentation • Apr 29, 2021
Investor Presentation
Open in ViewerOpens in native device viewer


April 29th 2021

All geographic areas reported a YoY increase in aggregated sales on like for like basis. Vaccines and re-openings offer a glimpse of return to normality. 1Q EBITDA up +40,9% YoY.
3m aggregated sales amounted to € 216,7m (unchanged compared to prior year, 4,0% on a like for like basis). Higher sales from commercial licensees offset delayed shipments from productive licensees.
Consolidated sales amounted to € 67,0m (-5,2% YoY), due to closure of directly operated stores in several European countries imposed by anti-Covid measures. Kappa Europe performed positively (+5,8%) despite the critical market situation in UK.
EBITDA at € 9,0m increased by 40,9% YoY with higher margins in all geographic areas, thanks to efficiency in general costs and lower cost of labour.
Net Financial Position at € 78,5m, decreased vs YE2020 (€ 82,2), thanks to a positive free cash flow exceeding € 3,8m.
€ 217m Aggregated Sales
€ 67m Consolidated Sales
€ 9m EBITDA

1


-5,2%
-6,8%
-0,9%
AGGREGATED SALES CONSOLIDATED SALES
54,4
67,0
8,6



in € .000


| in € .000 | 31.03.21 | 31.12.20 | 31.03.20 |
|---|---|---|---|
| Net Cash | (5.800) | (6.266) | (34.983) |
| ST portion of MT Loans | (8.518) | (8.412) | (8.095) |
| MT Loans | (42.442) | (44.387) | (19.406) |
| IFRS 16 debt | (21.767) | (23.097) | (17.916) |
| Put/call option | - | - | (2.839) |
| Net Financial Position: | (78.527) | (82.162) | (83.238) |
| Equity: | 124.644 | 119.276 | 123.870 |
| NFP/Equity: | 0,63 | 0,69 | 0,67 |










| Aggregated Sales of Licensees (ASL) | sales by commercial licensees | |
|---|---|---|
| Aggregated Sales of Sourcing Centers (ASSC) |
sales by productive licensees | |
| Communication investments | Sponsorship and media costs along with Commercial expenses | |
| Consolidated sales | the sum of royalties income from ASL, sourcing commissions from ASSC and direct sales of goods |


Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.